April 1, 2026 Elevance sidesteps Medicare Advantage sanctions for now April 1, 2026 Over 130 hospitals sue HHS over DSH payments April 1, 2026 Eli Lilly’s obesity pill approved by FDA, setting up fierce competition with Novo Nordisk April 1, 2026 Bipartisan lawmakers urge CMS to crack down on Medicare Advantage overpayments April 1, 2026 STAT+: Novo’s subscription model raises questions about pharma-telehealth tie-ups April 1, 2026 STAT+: Insilico Medicine CEO on how best to use AI in drug development April 1, 2026 STAT+: Pharmalittle: We’re reading about FDA view on peptide compounding, Iran war hurting trial recruitment, and more April 1, 2026 CMS tackles big policy changes with diminished workforce April 1, 2026 One year after HHS layoffs, a department in disarray April 1, 2026 STAT+: Can a psychedelic ‘coach’ make ketamine therapy even more effective? April 1, 2026 STAT+: NIH director’s invocation of Vannevar Bush’s legacy to promote Trump science policies sparks pushback April 1, 2026 STAT+: The biotech scorecard for the second quarter: 23 stock-moving events to watch April 1, 2026 Why an ovary syndrome may get a new name: Men seem to have PCOS, too April 1, 2026 Opinion: Medical marijuana should not be recommended for PTSD, anxiety, or depression April 1, 2026 Opinion: Medicare is restricting care for 1 million Americans based on a faulty assumption. Congress must intervene March 31, 2026 STAT+: The HSA industry makes its MAHA pitch March 31, 2026 HHS reverses Biden-era tech reorganization, returns ONC name March 31, 2026 STAT+: HHS changes the U.S. health IT office’s name, and its purview March 31, 2026 Elevance fills slew of mid-level leadership positions March 31, 2026 STAT+: Baby KJ scientists hit speed bump in quest to scale custom gene editor March 31, 2026 STAT+: OpenEvidence inks deal with major health system March 31, 2026 Supreme Court rules against Colorado ban on ‘conversion therapy’ for LGBTQ kids March 31, 2026 Lilly’s AI commitment expands through deal with Insilico March 31, 2026 STAT+: Pharmalittle: We’re reading about pharma delaying launches in Europe, Lilly and Biogen deals, and more March 31, 2026 A new survey examines mental health outcomes of gender euphoria March 31, 2026 STAT+: Psychedelic biotechs face scrutiny over YouTube promos March 31, 2026 STAT+: Whoop, maker of health and fitness tracking wristbands, valued at $10 billion after latest fundraising March 31, 2026 STAT+: Biogen to acquire immunology biotech Apellis for $5.6 billion March 31, 2026 STAT+: Eli Lilly to buy Centessa Pharmaceuticals, maker of a narcolepsy drug, in $6.3B deal March 31, 2026 Opinion: America needs more clinics of last resort for patients who can’t get answers March 31, 2026 Opinion: How the next CDC director can win back America’s trust March 31, 2026 STAT+: HSA companies struck it big in Trump’s tax bill. They’re lobbying for more March 31, 2026 STAT+: Over-the-top psychedelic promos could undermine the field’s drug development efforts March 31, 2026 STAT+: Biotech VCs move upstream in China’s scientific pipelines as competition grows fiercer March 31, 2026 STAT+: Jimini Health raises funding for AI chatbot targeting complex mental health care March 30, 2026 STAT+: Pharma giant Takeda to lay off nearly 250 workers in latest job cutting March 30, 2026 STAT+: Doctors Without Borders calls Gilead ‘unconscionable’ for refusing to sell HIV prevention drug to the organization March 30, 2026 STAT+: Why this Stanford psychiatrist thinks diet can influence serious mental health disorders March 30, 2026 STAT+: Early signs of Alzheimer’s often go undetected. These researchers want to change that March 30, 2026 Lead still raises risk of heart disease, years after exposure, study warns Previous Page 1 … 47 48 49 50 Next Page 2026-03-30
